Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 273 | 3 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//DRUG METABOLISM AND DISPOSITION | 43782 |
| 812 | 2 | P GLYCOPROTEIN//MULTIDRUG RESISTANCE//MDR1 | 12153 |
| 37446 | 1 | TCRP1//MIR 1284//ZINC FINGER PROTEIN 139 | 83 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | TCRP1 | authKW | 1898621 | 6% | 100% | 5 |
| 2 | MIR 1284 | authKW | 759448 | 2% | 100% | 2 |
| 3 | ZINC FINGER PROTEIN 139 | authKW | 683501 | 4% | 60% | 3 |
| 4 | MICRORNA 1284 | authKW | 506298 | 2% | 67% | 2 |
| 5 | ANGIOGENESIS CANC UK | address | 379724 | 1% | 100% | 1 |
| 6 | ARIA APOPTOSIS REGULATOR THROUGH MODULATING IAP EXPRESSION | authKW | 379724 | 1% | 100% | 1 |
| 7 | CANCER CHERNOTHERAPY | authKW | 379724 | 1% | 100% | 1 |
| 8 | CISPLATIN MIR 493 | authKW | 379724 | 1% | 100% | 1 |
| 9 | COMBINED INTERVENTIONAL THERAPY | authKW | 379724 | 1% | 100% | 1 |
| 10 | CYTOTOXICITY INTRODUCTION | authKW | 379724 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 676 | 47% | 0% | 39 |
| 2 | Cell Biology | 116 | 20% | 0% | 17 |
| 3 | Pathology | 47 | 7% | 0% | 6 |
| 4 | Medicine, Research & Experimental | 43 | 10% | 0% | 8 |
| 5 | Biochemistry & Molecular Biology | 34 | 20% | 0% | 17 |
| 6 | Biophysics | 25 | 7% | 0% | 6 |
| 7 | Gastroenterology & Hepatology | 16 | 5% | 0% | 4 |
| 8 | Hematology | 15 | 5% | 0% | 4 |
| 9 | Pharmacology & Pharmacy | 5 | 7% | 0% | 6 |
| 10 | Respiratory System | 4 | 2% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ANGIOGENESIS CANC UK | 379724 | 1% | 100% | 1 |
| 2 | FLOW CYTOMETRY EXPT HEPATOL SERV | 379724 | 1% | 100% | 1 |
| 3 | HOUSPITAL 4 | 379724 | 1% | 100% | 1 |
| 4 | SHENZHEN ENGN HIGH THROUGHPUT GENE SEQUENCING | 189861 | 1% | 50% | 1 |
| 5 | XJING HOSP | 189861 | 1% | 50% | 1 |
| 6 | DEV VASC BIOL PROGRAM | 162734 | 4% | 14% | 3 |
| 7 | DINO FERRARISTEM CELL | 126573 | 1% | 33% | 1 |
| 8 | RICU | 126573 | 1% | 33% | 1 |
| 9 | ANHUI PROV CANC HOSP | 101256 | 2% | 13% | 2 |
| 10 | CRI DEV VASC BIOL PROGRAM | 75943 | 1% | 20% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ONCOLOGY RESEARCH | 4698 | 5% | 0% | 4 |
| 2 | CELL BIOCHEMISTRY AND BIOPHYSICS | 2885 | 5% | 0% | 4 |
| 3 | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | 1431 | 6% | 0% | 5 |
| 4 | ONCOLOGY LETTERS | 912 | 5% | 0% | 4 |
| 5 | BIOSCIENCE TRENDS | 743 | 1% | 0% | 1 |
| 6 | THORACIC CANCER | 685 | 1% | 0% | 1 |
| 7 | JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH | 560 | 2% | 0% | 2 |
| 8 | SAUDI JOURNAL OF BIOLOGICAL SCIENCES | 546 | 1% | 0% | 1 |
| 9 | NANOMATERIALS | 532 | 1% | 0% | 1 |
| 10 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 452 | 4% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |